Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

<i>Aedes aegypti</i> database from SAGO traps. حسب Jesús A. Aguilar-Durán (9931967)

"…</p><p>Conclusion</p><p>Despite all treatments followed a reduction in mosquito populations, those that included AGO showed a greater decrease in post treatment populations than conventional control measures (IVM) alone. …"

Average days to heal a wound in 2022 and 2023. حسب Heba Tallah Mohammed (2822432)

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. حسب Haiwei Li (282229)

Statins resulted in smaller neuronal soma size. حسب Shuk C. Tsoi (21192243)

Data. حسب Su Hwan Park (15158181)

"…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …"

Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up. حسب Su Hwan Park (15158181)

Baseline characteristics of patients. حسب Su Hwan Park (15158181)

"…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …"

Simulation datasets. حسب Xiao Mo (2430355)

Relationships between clay and quartz content, TOC, 2D-NMR solid OM, S₁, 2D-NMR light oil and fractal dimensions. حسب Changjun Ji (18285907)

DataSheet1_Efficacy and safety of danshen class injections in the treatment of coronary heart disease: a network meta-analysis.docx حسب Shuang Dai (1413496)

"…The results of NMA showed that, XD injection significantly enhances clinical efficacy; STS is more effective in reducing hs-CRP levels; DSDFSY shows better efficacy in decreasing IL-1 and increasing NO levels; DSCXQ has a greater advantage in reducing IL-6 levels; GXN is more effective in regulating SOD levels; and DH is better at reducing MDA levels.…"

Table 1_Assessment of brain atrophy as a promising marker of radiological activity in patients with relapsing–remitting multiple sclerosis.docx حسب Aleksandra Pogoda-Wesołowska (14589242)

"…In the year-to-year analysis (n_CLAD = 59, n_ALEM = 36) within the CLAD group, new T2 lesions were significantly associated with a decrease in thalamic (p = 0.02), cerebellum (p = 0.05) and deep grey matter (p = 0.05) volume. …"